ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 50 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,551,000 | -9.8% | 2,415,000 | -9.4% | 0.01% | 0.0% |
| Q2 2017 | $2,827,000 | +10.1% | 2,665,000 | 0.0% | 0.01% | +12.5% |
| Q1 2017 | $2,567,000 | +41.3% | 2,665,000 | +36.5% | 0.01% | +33.3% |
| Q3 2016 | $1,817,000 | +21.6% | 1,953,000 | -7.6% | 0.01% | 0.0% |
| Q2 2016 | $1,494,000 | – | 2,113,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |